Injectsense Revenue and Competitors
Employee Data
- Injectsense has 14 Employees.
- Injectsense grew their employee count by 8% last year.
Injectsense's People
Name | Title | Email/Phone |
---|
Injectsense Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 19 | 6% | N/A | N/A |
#2 | $7.5M | 99 | -1% | $38.2M | N/A |
#3 | N/A | 8 | 100% | N/A | N/A |
#4 | N/A | 14 | 8% | N/A | N/A |
#5 | N/A | 5 | 25% | N/A | N/A |
#6 | $35M | 194 | -5% | $383.7M | N/A |
#7 | N/A | 51 | 59% | N/A | N/A |
#8 | $15M | 253 | 8% | $100M | N/A |
What Is Injectsense?
Injectsense: Improved Care Through Continuous Information\n\nInjectsense enables tracking of progressive disease indicators and improved therapy management by providing continuous, clinically actionable information through an injectable ultra-miniature sensor coupled with a secure digital health platform. Our sensor, which can be delivered during a single doctor's office visit, transforms the care model by enabling medical teams to track the disease at the pace of its evolution, whether months or years, receive early warning signs and provide preventive therapy. The configurable-on-demand sensor monitors patients 24/7, requires no patient lifestyle changes and reduces the need for medical office visits. More significantly, it allows physicians to establish an individual patient baseline for comparison, to receive data quickly at any time of day, to see histories and hourly dynamic disease state before irreversible damage is done, and to increase the effectiveness of drug therapy by tracking the effects of pharmaceuticals on key indicators over time.
keywords:N/AN/A
Total Funding
14
Number of Employees
N/A
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.8M | 15 | -6% | N/A |
#2 | $2.5M | 16 | -24% | N/A |
#3 | $1.4M | 16 | -6% | N/A |
#4 | $3.1M | 19 | -10% | N/A |
#5 | $1.7M | 20 | 0% | N/A |